Free Newsletter
Dolly creator scraps cloning, takes new approach
The renowned cloning scientist Ian Wilmut says he's abandoning cloning as a source of medical cures in favor of a new approach that creates stem cells from skin fragments. The new stem cell approach was first developed in Japan by Professor Shinya Yamanaka. Wilmut, who famously cloned Dolly the sheep 10 years ago, calls Yamanaka's discovery "extremely exciting and astonishing." By creating various stem cells from skin fragments, scientists believe they can invent cures for a variety of human ailments, like Alzheimer's, Parkinson's and more. And by using a patient's own skin tissue, they can avoid the threat of rejection. Wilmut's high profile could add to the move away from cloning human embryos as a source of therapeutic stem cells--a field that has been mired in controversy even as it advances steadily closer to the reach of scientists. Only last week we reported about a major advance in cloning primate embryos.
- check out the article from The Guardian
Related Articles:
Ian Wilmut discusses how regulations affect stem cell science. Report
Mature stem cells prove effective in cloning. Report
Single-parent stem cells may skirt cloning controversy. Report
Disgraced scientist back at work on cloned embryos. Report
Researcher promises cloned embryonic stem cells. Report
Comments
Post new comment
Paid Research Reports
- Stakeholder Opinions: Vaccines in Emerging Markets (Asia) - Opportunities in China, India, South Korea and Taiwan
- Big Pharma Performance Before, During and Beyond the Global Recession
- Optimizing Lifecycle Management: Maximizing commercial lifespan through label expansion and combination products
- The CRO Market Outlook: Emerging markets, leading players and future trends
- Pharmaceutical Sales Force Effectiveness Strategies
- Commercial Insight: Influenza Vaccines and Antivirals - The pandemic's long-term impact




